Ask Us
Please correct the highlighted fields below.

Alerts for Alendronate

Title Date Published Source
L’EMA confirme le risque de fracture atypique avec les médicaments contenant un biphosphonate (alendronate, clodronate, étidronate, ibandronate, pamidronate, risedronate, tiludronate, zolédronate) 2012-01-04
FDA Reviewing of Oral Bisphosphonates and Potential Increased Risk of Esophageal Cancer 2011-07-22
Healthcare Professionals Advised Of Potential Risk Of Atypical Fractures of the Thigh With Bisphosphonates 2011-06-07
Europäische Arzneimittelbehörde warnt vor Knochenbrüchen am Oberschenkel durch Osteoporose-Medikamente 2011-05-19
Benefits of Bisphosphonates Continue to Outweigh Risks 2011-05-06
La Agencia Europea De Medicamentos Revisa La Seguridad De Los Bisfosfonatos 2011-05-02
Europe-wide Review Shows Insufficient Evidence To Prove Link Between Oral Biphosphonates And Oesophageal Cancer 2010-12-14
FDA Updates Prescribing Information to Warn of Possible Fracture Risk With Osteoporosis Drugs 2010-10-13
European Medicines Agency To Review Safety of Bisphosphonates 2010-09-24
FDA Issues Statement on Possible Increased Risk of Rare Bone Fractures with Long-Term Bisphosphonate Use 2010-09-19
FDA Publishes Results of Ongoing Safety Review of Oral Bisphosphonates and Femur Fractures 2010-03-11
Update on FDA Safety Review of Bisphosphonates 2008-11-13
Use of alendronate (Fosamax) by women associated with an increased risk of an abnormal heart rhythm 2008-08-13
New Consumer Guide for Patients 2008-07-03
FDA Communication Regarding Musculoskeletal Pain 2008-01-07
Early communication of ongoing safety review 2007-10-01

See alerts for all drugs

Tell a friend

DISCLAIMER: MediGuard is not intended to be a substitute for professional medical advice. MediGuard cannot and does not take into consideration every possible interaction or account for individual responses to medicine. Different individuals may respond to medication in different ways. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Always seek the advice of a qualified health provider with any questions you may have before making any changes to your treatment. The use of the MediGuard site and its content is at your own risk. The MediGuard site and the information contained in it is intended for users in the United States and information in other countries may be different.

Popular Terms: Lisinopril Side Effects, Plavix Side Effects, Copaxone Information, Metformin, Methotrexate Interactions

HACKER SAFE certified sites prevent over 99.9% of hacker crime.